Ferraris Premium Brand Strategy Draws Market Attention Heard on the Street
Saudi Arabias Vision 2030 Spending Spree Encounters Fiscal Constraints
Traders Bet on IonQ Micron Anduril as Next US Government Stake Targets
Life360 Reports Record Q1 2026 Results With Subscription and Advertising Revenue Surge
Why Chasing Returns May Undermine LongTerm Investment Goals
Perpetua Resources Secures 29 Billion US Loan for Idaho GoldAntimony Project Amid Critical Mineral Push
VELO Q1 2026 Earnings Narrowed Loss Exceeds Expectations Shares Rise 9
Genpact G Q1 2026 Earnings EPS Beats Estimates Stock Slips Despite Strong Surprise
AKAM Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly
INSM Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction
Teads Holding Co TEAD Q1 2026 Earnings EPS Beats Expectations by 257 Amid Challenging Ad Market Stock Slips
Kustom Entertainment Inc KUST Q4 2025 Earnings EPS Falls Far Short of Estimates Amidst Disclosed Revenue Gap
Nuveen Municipal Credit Opportunities Fund NMCO Edges Higher Amid Steady Income Demand
Acorn Energy Inc ACFN Slips Slightly as Stock Holds Above Key Support
Odyssey Marine Exploration OMEX Edges Higher as Price Action Stabilizes Near Support
Lattice Semiconductor Holds Steady Near Key Support Amid Sector Volatility
First Advantage FA Trading Lower as Stock Tests Key Support Levels
Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project
Lessons from Ebola Outbreak Speed Funding and Compassion May Guide Future Pandemic Preparedness
SpaceX IPO Speculation Nvidia Earnings and Bezoss AI Bubble Comments Lead Morning Market Briefing
Federal Reserve Dissenters Explain Votes Against Statement Hinting at Next Rate Cut
Chime CHYM Reports 647M Revenue in Q1 2026 Marks First GAAP Profitable Quarter
Apollo Hospitals Grasim Varun Beverages Among BSE 100 Stocks Hitting 52Week Highs
Trumps AntiWeaponization Fund Faces Backlash from MAGA Base Poll Shows
Nyxoah NYXH Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Sleep Apnea Pipeline
AgomAb Therapeutics AGMB Gains 366 as Buyers Defend Key Support Level